Literature DB >> 25900210

A look behind the scenes: the risk and pathogenesis of primary osteoporosis.

Gretl Hendrickx1, Eveline Boudin1, Wim Van Hul1.   

Abstract

Osteoporosis is a common disorder, affecting hundreds of millions of people worldwide, and characterized by decreased bone mineral density and increased fracture risk. Known nonheritable risk factors for primary osteoporosis include advanced age, sex-steroid deficiency and increased oxidative stress. Age is a nonmodifiable risk factor, but the influence of a person's lifestyle (diet and physical activity) on their bone structure and density is modifiable to some extent. Heritable factors influencing bone fragility can be monogenic or polygenic. Osteogenesis imperfecta, juvenile osteoporosis and syndromes of decreased bone density are discussed as examples of monogenic disorders associated with bone fragility. So far, the factors associated with polygenic osteoporosis have been investigated mainly in genome-wide association studies. However, epigenetic mechanisms also contribute to the heritability of polygenic osteoporosis. Identification of these heritable and nonheritable risk factors has already led to the discovery of therapeutic targets for osteoporosis, which emphasizes the importance of research into the pathogenetic mechanisms of osteoporosis. Accordingly, this article discusses the many heritable and nonheritable factors that contribute to the pathogenesis of primary osteoporosis. Although osteoporosis can also develop secondary to many other diseases or their treatment, a discussion of the factors that contribute only to secondary osteoporosis is beyond the scope of this Review.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25900210     DOI: 10.1038/nrrheum.2015.48

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  148 in total

1.  Dietary protein content and the diet's net acid load: opposing effects on bone health.

Authors:  Anthony Sebastian
Journal:  Am J Clin Nutr       Date:  2005-11       Impact factor: 7.045

Review 2.  Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?

Authors:  R Sapir-Koren; G Livshits
Journal:  Osteoporos Int       Date:  2014-07-17       Impact factor: 4.507

Review 3.  How many women have osteoporosis now?

Authors:  L J Melton
Journal:  J Bone Miner Res       Date:  1995-02       Impact factor: 6.741

4.  Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density.

Authors:  Somayyeh Fahiminiya; Jacek Majewski; Peter Roughley; Paul Roschger; Klaus Klaushofer; Frank Rauch
Journal:  Bone       Date:  2013-07-23       Impact factor: 4.398

5.  p53 mutant mice that display early ageing-associated phenotypes.

Authors:  Stuart D Tyner; Sundaresan Venkatachalam; Jene Choi; Stephen Jones; Nader Ghebranious; Herbert Igelmann; Xiongbin Lu; Gabrielle Soron; Benjamin Cooper; Cory Brayton; Sang Hee Park; Timothy Thompson; Gerard Karsenty; Allan Bradley; Lawrence A Donehower
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

6.  Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency.

Authors:  B D Gelb; G P Shi; H A Chapman; R J Desnick
Journal:  Science       Date:  1996-08-30       Impact factor: 47.728

Review 7.  Autophagy and aging.

Authors:  David C Rubinsztein; Guillermo Mariño; Guido Kroemer
Journal:  Cell       Date:  2011-09-02       Impact factor: 41.582

Review 8.  Antioxidants and human diseases.

Authors:  Peramaiyan Rajendran; Natarajan Nandakumar; Thamaraiselvan Rengarajan; Rajendran Palaniswami; Edwinoliver Nesamony Gnanadhas; Uppalapati Lakshminarasaiah; Jacob Gopas; Ikuo Nishigaki
Journal:  Clin Chim Acta       Date:  2014-06-13       Impact factor: 3.786

9.  Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

Authors:  Takashi Nakamura; Yuuki Imai; Takahiro Matsumoto; Shingo Sato; Kazusane Takeuchi; Katsuhide Igarashi; Yoshifumi Harada; Yoshiaki Azuma; Andree Krust; Yoko Yamamoto; Hiroshi Nishina; Shu Takeda; Hiroshi Takayanagi; Daniel Metzger; Jun Kanno; Kunio Takaoka; T John Martin; Pierre Chambon; Shigeaki Kato
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

10.  Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade.

Authors:  Jin-Ran Chen; Kartik Shankar; Shanmugam Nagarajan; Thomas M Badger; Martin J J Ronis
Journal:  J Pharmacol Exp Ther       Date:  2007-10-04       Impact factor: 4.030

View more
  73 in total

1.  Association of gout with osteoporotic fractures.

Authors:  Yanmao Wang; Runhua Zhou; Wanrun Zhong; Chengfang Hu; Shengdi Lu; Yimin Chai
Journal:  Int Orthop       Date:  2018-06-28       Impact factor: 3.075

Review 2.  Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.

Authors:  P Trejo; F Rauch
Journal:  Osteoporos Int       Date:  2016-08-05       Impact factor: 4.507

3.  Comparison of diclofenac with apigenin-glycosides rich Clinacanthus nutans extract for amending inflammation and catabolic protease regulations in osteoporotic-osteoarthritis rat model.

Authors:  Nur Adeelah Che Ahmad Tantowi; Suhaila Mohamed; Seng Fong Lau; Paisal Hussin
Journal:  Daru       Date:  2020-05-09       Impact factor: 3.117

Review 4.  Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review.

Authors:  Marc Bienz; Fred Saad
Journal:  Bonekey Rep       Date:  2015-06-24

5.  MiR-148a the epigenetic regulator of bone homeostasis is increased in plasma of osteoporotic postmenopausal women.

Authors:  Ajda Bedene; Simona Mencej Bedrač; Lea Ješe; Janja Marc; Peter Vrtačnik; Janez Preželj; Tomaž Kocjan; Tilen Kranjc; Barbara Ostanek
Journal:  Wien Klin Wochenschr       Date:  2016-11-29       Impact factor: 1.704

Review 6.  Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism.

Authors:  Christian Santa Maria; Zhiqiang Cheng; Alfred Li; Jiali Wang; Dolores Shoback; Chia-Ling Tu; Wenhan Chang
Journal:  Semin Cell Dev Biol       Date:  2015-12-10       Impact factor: 7.727

Review 7.  Clinical immunity in bone and joints.

Authors:  Yoshiya Tanaka
Journal:  J Bone Miner Metab       Date:  2018-10-15       Impact factor: 2.626

8.  Molecular diagnosis in children with fractures but no extraskeletal signs of osteogenesis imperfecta.

Authors:  G Bardai; L M Ward; P Trejo; P Moffatt; F H Glorieux; F Rauch
Journal:  Osteoporos Int       Date:  2017-04-04       Impact factor: 4.507

9.  1,25-Dihydroxyvitamin D insufficiency accelerates age-related bone loss by increasing oxidative stress and cell senescence.

Authors:  Wanxin Qiao; Shuxiang Yu; Haijian Sun; Lulu Chen; Rong Wang; Xuan Wu; David Goltzman; Dengshun Miao
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

Review 10.  Recent advances in the epigenetics of bone metabolism.

Authors:  Yuexin Xu; Jing Ma; Guohua Xu; Duan Ma
Journal:  J Bone Miner Metab       Date:  2021-07-11       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.